NLSP icon

NLS Pharmaceutics
NLSP

Overview Fund Activity

5 hedge funds and large institutions have $7.47M invested in NLS Pharmaceutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
1
BVF Inc
California
$7.41M
2
UBS Group
2
UBS Group
Switzerland
$12.7K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
TSS
2
Two Sigma Securities
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$26K
Name Holding Trade Value Shares
Change 		Shares
Change %
BI
1
BVF Inc
California
$7.41M +$7.41M +143,678 New
Renaissance Technologies
2
Renaissance Technologies
New York
$26K -$7.21K -140 -22%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$18K – – –
UBS Group
4
UBS Group
Switzerland
$12.7K +$12.7K +246 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
– -$36K -1,437 Closed
TSS
6
Two Sigma Securities
New York
– -$11K -441 Closed